Angela Jain, MD, details ongoing challenges with identifying optimal treatments for patients with triple-negative breast cancer.
Angela Jain, MD
Advertisement
Angela Jain, MD, is an associate professor, Department of Hematology/Oncology; interim chief of the Division of Breast Medical Oncology; and chief of the Division of Gynecologic Medical Oncology, of Fox Chase Cancer Center.
Articles by Angela Jain, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Unpacking the FDA Approvals That Reshaped Cancer Care in 2025
2
Relacorilant Plus Nab-Paclitaxel Meets OS End Point of ROSELLA Trial in PROC
3
Nogapendekin Alfa Inbakicept Plus NK Cell Therapy Yields Strong OS Signal in Recurrent Glioblastoma
4
Immune-Targeting Vaccine Shows Promise Intercepting Cancer in Patients With Lynch Syndrome
5